FindTrial
Sign In

Development of cancer immune evaluation tool

Development of a cancer diagnostic tool by way of evaluating peripheral blood immunity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002469
Enrollment
500
Registered
2017-09-15
Start date
2016-10-03
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul Songdo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with colorectal cancer confirmed by radiologic imaging and histological test 2. those who over 20 years old 3. patients who understand study and signed an informed consent

Exclusion criteria

Exclusion criteria: 1. patients experienced with incidence or surgery of other cancers 2. Recurred patients with colorectal cancer

Design outcomes

Secondary

MeasureTime frame
Cytokines, chemokines, cancer growth and angiogenesis factors—

Primary

MeasureTime frame
expression level of primary receptors on suppressive immune cells such as regulatory T cells and Myeloid-derived suppressor cells—

Countries

Korea, Republic of

Contacts

Public ContactJoungbum Choi

Seoul Songdo Hospital

jounnn@gmail.com+82-2-2250-7848

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026